Menarini
PharmaFlorence, Italy, Italy · Est. 1886 · 17,000 employees
Menarini is an Italian multinational pharmaceutical company producing generic drugs, specialty pharmaceuticals, and diagnostic products for cardiovascular, gastroenterology, and respiratory diseases.
1
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
1
Indications↗
Distinct diseases across all programs
28
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
Pipeline Snapshot
By Phase
1 drugs in development
Phase 21
By Therapeutic Area
top 1
Infectious Disease
1100%
R&D Momentum
12/100
Pipeline Velocity
0/100
Trial Completion Rate
70/100
Pipeline Concentration
100/100
Pipeline Freshness
86/100
Activity
Key Events
Feb 18, 2025TrialA Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections
Jul 20, 2020TrialMEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
Sep 25, 2019TrialDelafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Nov 13, 2018TrialMEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Aug 28, 2017TrialMEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study
Mar 10, 2017TrialMEN1703 (SEL24) in Participants With Acute Myeloid Leukemia
Feb 27, 2017TrialFebuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults
Details
Company Info
Company Overview
—
Mkt Cap
$3.8B
Revenue
—
Cash
CEOElcin Barker Yildirim
Founded1886
Employees17,000
HQFlorence, Italy, Italy
Websitemenarini.com
LinkedInCompany Page
Therapeutic Focus
CardiovascularGastroenterologyRespiratoryOncology
Pipeline
Drug Pipeline
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Infectious Disease
Infectious Disease
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)